9-14 March 2021
15th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2021
Location: entirely virtual meeting
e-Poster Title: “TOPLINE ETHERAL PHASE II TRIAL DATA”
Presenter: Dr. Michael Ropacki, CMO of CNS at Oryzon
e-Poster Title: “REIMAGINE-AD VAFIDEMSTAT SHOWS EFFICACY IN ALZHEIMER-RELATED AGITATION & AGGRESSION AFTER 12 MONTHS”
Presenter: Dr. Carlos Buesa, Oryzon’s CEO